Does thrombophilia testing help in the clinical management of patients?

S Middeldorp… - British journal of …, 2008 - Wiley Online Library
Thrombophilia can be identified in about half of all patients presenting with venous
thrombosis. Testing has increased tremendously for various indications, but whether the …

[HTML][HTML] Different effects of oral contraceptives containing different progestogens on protein S and tissue factor pathway inhibitor

H Van Vliet, RM Bertina, AEA Dahm… - Journal of Thrombosis …, 2008 - Elsevier
Background: Oral contraceptives (OC) containing different types of progestogens induce
different sensitivities to activated protein C (APC) measured with the thrombin generation …

Effects of oral and transdermal hormonal contraception on vascular risk markers: a randomized controlled trial

JV Johnson, J Lowell, GJ Badger, J Rosing… - Obstetrics & …, 2008 - journals.lww.com
OBJECTIVE: To compare the effects of oral and transdermal contraceptives containing
similar hormone formulations on vascular risk markers. METHODS: We conducted a …

Effects of conventional or extended-cycle regimen of an oral contraceptive containing 30 mcg ethinylestradiol and 2 mg dienogest on various hemostasis parameters

I Wiegratz, S Stahlberg, T Manthey, N Sänger… - Contraception, 2008 - Elsevier
BACKGROUND: The study was conducted to investigate the effect of a combined oral
contraceptive (COC) containing 30 mcg ethinylestradiol and 2 mg dienogest with two …

Venous thrombosis in oral contraceptive users and the presence of the JAK2 V617F mutation

E Grandone, D Colaizzo, GL Tiscia… - Thrombosis and …, 2008 - thieme-connect.com
Dear Sir, Oral contraceptive (OC) use is known to be associated with increased risk of
venous thromboembolism (VTE). OCs induce changes in coagulation and fibrinolysis …

Update thrombophilie

E Lindhoff-Last, B Luxembourg, I Pabinger - Hämostaseologie, 2008 - thieme-connect.com
Es wird ein Überblick über Definitionen, Epidemiologie, Klinik der angeborenen und
erworbenen Thrombophilien gegeben, wobei der Fokus auf evidenzbasierten Daten liegt …

Düşük dozlu oral kontraseptif steroidlerin, ateroskleroz, kardiyovasküler hastalık ve damar endotel hasar belirteçleri üzerine etkileri

Z Güner - 2008 - adudspace.adu.edu.tr
Kardiyovasküler hastalıklar önemli morbidite ve mortalite nedenleri arasında yer almaktadır.
Bu hastalıklara ilişkin risk faktörlerinin belirlenmesi koruyucu önlemlerin alınması açısından …

[PDF][PDF] Fisiopatología del sistema hemostático en la mujer

A Estellés, J Gilabert-Estellés, E Zorio, LA Ramón… - L Reunión Nacional de la … - sehh.es
A lo largo de la vida de la mujer existen diversas situaciones, tales la anticoncepción
hormonal, la terapia hormonal sustitutiva, la gestación y el puerperio, en las que se puede …

11 Warfarin and Cotrimoxazole: Averting Disaster

TR Marcy - ASHP's Clinical Pearls, 2008 - books.google.com
Warfarin is an anticoagulant drug used for the prevention and treatment of thromboembolic
disorders, such as venous thromboembolism and cardioembolic stroke. 1 Patients with a …

Oral Contraception and Thrombophilia

D Blickstein, I Blickstein - Topics in Obstetrics & Gynecology, 2008 - journals.lww.com
Oral Contraception and Thrombophilia : Topics in Obstetrics & Gynecology Oral Contraception
and Thrombophilia : Topics in Obstetrics & Gynecology Log in or Register Subscribe to …